MRTX
Neuberger Berman Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-7,225
| Closed | -$424K | – | 1950 |
|
|
2023
Q4 | $424K | Sell |
7,225
-19,638
| -73% | -$1.15M | ﹤0.01% | 1537 |
|
|
2023
Q3 | $1.17M | Buy |
26,863
+8,723
| +48% | +$380K | ﹤0.01% | 1211 |
|
|
2023
Q2 | $655K | Buy |
18,140
+1,734
| +11% | +$62.6K | ﹤0.01% | 1362 |
|
|
2023
Q1 | $610K | Buy |
16,406
+1,180
| +8% | +$43.9K | ﹤0.01% | 1399 |
|
|
2022
Q4 | $690K | Sell |
15,226
-3,128
| -17% | -$142K | ﹤0.01% | 1349 |
|
|
2022
Q3 | $1.28M | Sell |
18,354
-654
| -3% | -$45.7K | ﹤0.01% | 1195 |
|
|
2022
Q2 | $1.28M | Buy |
19,008
+1,746
| +10% | +$117K | ﹤0.01% | 1221 |
|
|
2022
Q1 | $1.42M | Sell |
17,262
-69,903
| -80% | -$5.75M | ﹤0.01% | 1270 |
|
|
2021
Q4 | $12.3M | Buy |
+87,165
| New | +$12.3M | 0.01% | 787 |
|
|
2021
Q3 | – | Sell |
-20,257
| Closed | -$3.27M | – | 1829 |
|
|
2021
Q2 | $3.27M | Buy |
20,257
+2,584
| +15% | +$417K | ﹤0.01% | 1066 |
|
|
2021
Q1 | $3.03M | Buy |
17,673
+434
| +3% | +$74.3K | ﹤0.01% | 1067 |
|
|
2020
Q4 | $3.79M | Buy |
+17,239
| New | +$3.79M | ﹤0.01% | 979 |
|
|
2019
Q2 | – | Sell |
-6,000
| Closed | -$440K | – | 1594 |
|
|
2019
Q1 | $440K | Buy |
+6,000
| New | +$440K | ﹤0.01% | 1283 |
|